This is surprising -- and not good news -- for women. For women who carry one of two specific gene mutations, BRCA1 or BRCA2, linked to an increase in breast and ovarian cancer risk, even if the ovaries and fallopian tubes are surgically removed, they are still at risk for developing a form of ovarian cancer called peritoneal cancer. According to Dr. Steven Narod, a leading researcher in the field of inherited breast and ovarian cancers, women with the gene mutations still have a cancer risk nine times higher than women without the inherited BRCA1 or BRCA2 gene mutation.
"Is it bad news? Well, one would like to think you have your organs removed and the disease is not going to come," said Dr. Narod. The average Canadian woman has about a 1.4 percent lifetime risk of developing ovarian cancer. The risks for women with the BRCA1 gene mutation is 60 percent and with the BRCA2 gene mutation is 25 percent.
Researchers call the surgical removal of ovaries and fallopian tubes a method of risk-reduction but that it will not completely prevent ovarian cancer. The Hereditary Ovarian Cancer Clinical Study Group have reported the study results in the Journal of the American Medical Association.











1. If I ONLY read YOUR title and summary and I was debating this decision for myself, boy would I make the wrong choice. From:
1.Removal of ovaries does not prevent ovarian cancer
2.This surprising - and not good news-...
3.women with the gene mutations still have a cancer risk nine times higher than women without the inherited BRCA1 or BRCA2 gene mutation
4.[it's a]method of risk-reduction but that it will not completely prevent ovarian cancer.
Wow. The heck with removing them. Right?
Wrong. You say this non-preventive, surprising-not good-news means that even if you remove the ovaries, your risk is still 9x higher. Nine times higher than what?
The observed incidence of cancer among the women with intact ovaries was 1,015 per 100,000 per year --about 58 times the incidence in the general population, the researchers reported. By contrast, the incidence among women who had a prophylactic bilateral salpingo-oophorectomy was 217 per 100,000 per year (4.3%) -- only 9.3 times the expected rate for the general population.
And 4.3% may actually be too high as "it is possible that these are actually metastases of subclinical disease that was present at the time of surgery."
I've chosen a different statement from the same author:
Women with mutations in BRCA1 and BRCA2 are at sharply increased risk for ovarian cancer, and it is standard practice for physicians to recommend a salpingo-oophorectomy, but only about 60% of women follow through and have the surgery. "I would like to see it be 100%," Dr. Narod said, as soon as women are at or near the end of their child-bearing years.
"These cancers are not detectable early, the mortality rate is 80% -- if they get it most people succumb to it -- and they can't be screened for," he said. "So that leaves prevention."
http://www.medpagetoday.com/HematologyOncology/OtherCancers/tb/3713
Posted at 12:29PM on Jul 12th 2006 by Michelle